Upload
bananaip-counsels
View
93
Download
0
Embed Size (px)
Citation preview
Intro to Patent Law – Section 3(d)
Dr. Kalyan C. Kankanala
Blog: http://sinapse.bananaip.com
Books: www.kalyankankanala.com
© BananaIP Counsels. 2015. Private Use is Permitted.
Inventor/ Investor
Incentives
Public Domain
Invention
Patent
Patent RegimeGive and Take
Progress of Science and Technology
Invent
Invest
Disclose
Design
Around
Patentability Requirements
Patentable subject matter
Industrial Applicability
Novelty
Inventive Step
Specification
© BananaIP Counsels. 2015. Private Use is Permitted.
Patentable Subject Matter
Eligible Subjects
Product or Process - Section 2(1)(j)
Exclusions
Sections 3 and 4 - Non-Patentable Subjects/Inventions
© BananaIP Counsels. 2015. Private Use is Permitted.
Exclusions
Section 3(d)
New form of Known Substance
Enhanced/Significant Efficacy
New property
New use
© BananaIP Counsels. 2015. Private Use is Permitted.
Section 3(d)
Explanation:... salts, esters, ethers, polymorphs, metabolites, pure form, particle size, isomers, mixtures of isomers, complexes, combinations and other derivatives of known substance shall be considered to be the same substance, unless they differ significantly in properties with regard to efficacy.
© BananaIP Counsels. 2015. Private Use is Permitted.
Section 3(d)
Examples
New Property: Lower ethers are highly volatile and flammable.
New Use: Use of Metformin for treating fatty liver disorder, when it is known for diabetes treatment.
New Form: Imatinib Masylate in Beta Crystalline form for treating cancer, when Imatinib was known for cancer treatment.
Enhanced Efficacy?
© BananaIP Counsels. 2015. Private Use is Permitted.
Section 3(d)
• Which is the known substance?
• Is the invention a new form of that substance?
• Does the invention have enhanced efficacy?
© BananaIP Counsels. 2015. Private Use is Permitted.
Example
Known Analgesics
Morphine - NarcoticDiclofenac - Non-Narcotic
Invention
morphine-diclofenateflupirtin and morphine combination
© BananaIP Counsels. 2015. Private Use is Permitted.
ExampleKnown Substances
• Human Genome• cDNA sequences for six eye colour variations• cDNA sequence for hair color
Invention
• Re-combinant DNA Blue-Green eyes and Blonde hair• Method of introducing the same in Mammalian cells• Organism with blue eyes and blonde hair
© BananaIP Counsels. 2015. Private Use is Permitted.
Example
Known Substances
PCRTaq PolymeraseSolid Wax Barrier or Antibody ligation to prevent
DNA synthesis at low temperature
Invention
Chemically modified Taq Polymerase - Inactive at low temperature, and active at high temperature.
© BananaIP Counsels. 2015. Private Use is Permitted.
Example
•Known Substance
Straws with filtration up to 1 micron
•Invention
Straw with filtration up to 0.2 micron
© BananaIP Counsels. 2015. Private Use is Permitted.
Example
• Known substanceStentTaxol
Invention- Stent coated with taxol
© BananaIP Counsels. 2015. Private Use is Permitted.
S. 3(d) V. Other Requirements
Industrial Applicability
Novelty
Inventive Step
Specification
© BananaIP Counsels. 2015. Private Use is Permitted.
CASE CASE CITATION
Novartis A.G v. Union of IndiaCivil Appeal Nos. 2706-2716 of 2013 (S.L.P. (C) Nos. 20539-20549 of 2009).
Jeevan Jyoti Health & Welfare Society vs. Union of India & Anr. W.P. (C) 10634/2006.
F. Hoffmann - La Roche Ltd. and Anr. vs. Cipla Limited I.A. 642/2008 in CS (OS) 89/2008.
Takeda GmBH v. Controller of Patents and Designs 293/MUMNP/2008.
Asian Electronics Ltd. vs. Havells India Limited I.A. No. 8205/2009 in CS(OS) 1168/2009.
Otsuka Pharmaceutical Co. Ltd. vs. The Controller General of Patents & Deputy Controller of Patents & Designs
OA/24/2010/PT/DEL.
Ten Xc Wireless Inc & Anr vs Mobi Antenna Technologies CS(OS) Nos. 1989/2010.
Fresenius Kabi Oncology Limited Vs. Glaxo Group Limited and The Controller of Patents
ORA/22/2011/PT/KOL.
Fresenius Kabi Oncology Limited Vs. Glaxo Group Limited and The Controller of Patents
ORA/17/2012/PT/KOL.
Monsanto Technology LLC Vs. The Controller of Patents & Designs and The Deputy Controller of Patents & Designs
OA/02/2012/PT/DEL., M.P. NOS.35 & 36/2013 IN OA/02/2012/PT/DEL.
Cima Labs Inc. vs. The Controller of Patents OA/2/2013/PT/KOL.
Merck Sharp and Dohme Corporation and Ors. vs. Glenmark Pharmaceutical
FAO (OS) 190/2013., C.M. Appl. 5755/2013., 466 & 467/2014.
3M Innovative Properties Company Vs.Venus Safety & Health Pvt. Ltd.
I.A. No. 20605/2013., I.A. No. 1276/2014 in CS(OS)--2558/2013.
Novartis A. G. vs. Ranbaxy Laboratories Ltd I.A. No. 17139/2014 in CS (OS) No. 2703/2014.
Novartis AG vs. Cipla Ltd I.A. No. 24863/2014 in CS (OS) 3812/2014.
Pfizer Products Inc. vs. Controller of Patents OA/41/2014/PT/MUM.
Telefonaktiebolaget Lm Ericsson ( Publ ) vs. Intex Technologies I.A. No. 6735/2014 in CS (OS) No. 1045/2014.
Gilead Pharmasset , LLC vs. Union of India and Ors WP (C) 687/2015 and CM No. 1222/2015.
© BananaIP Counsels. 2015. Private Use is Permitted.
Available On
© BananaIP Counsels. 2015. Private Use is Permitted. [email protected]
Dr. Kalyan’s Book Collection
Thank You!
Kalyan C Kankanala
© BananaIP Counsels. 2015. Private Use is Permitted.